sodium 1-(5-(benzo[d][1,3]dioxol-5-ylmethylamino)-6-chloroquinazolin-2-yl)piperidine-4-carboxylate

ID: ALA4552529

PubChem CID: 155556194

Max Phase: Preclinical

Molecular Formula: C22H20ClN4NaO4

Molecular Weight: 440.89

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C([O-])C1CCN(c2ncc3c(NCc4ccc5c(c4)OCO5)c(Cl)ccc3n2)CC1.[Na+]

Standard InChI:  InChI=1S/C22H21ClN4O4.Na/c23-16-2-3-17-15(11-25-22(26-17)27-7-5-14(6-8-27)21(28)29)20(16)24-10-13-1-4-18-19(9-13)31-12-30-18;/h1-4,9,11,14,24H,5-8,10,12H2,(H,28,29);/q;+1/p-1

Standard InChI Key:  XWNFBLFXLFUAST-UHFFFAOYSA-M

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   10.9454   -9.0345    0.0000 Na  0  0  0  0  0 15  0  0  0  0  0  0
    3.4324   -7.1813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4313   -8.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1393   -8.4098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1375   -6.7725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8462   -7.1777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8469   -7.9968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5555   -8.4038    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2637   -7.9930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2590   -7.1709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5499   -6.7675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7246   -6.7729    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.1351   -5.9553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8416   -5.5446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8392   -4.7274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5475   -4.3212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5454   -3.5047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1327   -4.3276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1271   -3.5125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8343   -3.1011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6616   -2.3014    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8476   -2.2185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5174   -2.9671    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9730   -8.3988    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9719   -9.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6771   -9.6183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3857   -9.2104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3844   -8.3923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6747   -7.9820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0934   -9.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0935  -10.4362    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8011   -9.2103    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  7  2  0
  6  5  2  0
  5  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  2 12  1  0
  5 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 20  2  0
 19 18  2  0
 18 15  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 19  1  0
  9 24  1  0
 24 25  1  0
 24 29  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 27 30  1  0
 30 31  2  0
 30 32  1  0
M  CHG  2   1   1  32  -1
M  END

Associated Targets(Human)

PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 440.89Molecular Weight (Monoisotopic): 440.1251AlogP: 3.93#Rotatable Bonds: 5
Polar Surface Area: 96.81Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.85CX Basic pKa: 5.01CX LogP: 2.15CX LogD: 0.82
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.62Np Likeness Score: -1.17

References

1. Pobsuk N, Paracha TU, Chaichamnong N, Salaloy N, Suphakun P, Hannongbua S, Choowongkomon K, Pekthong D, Chootip K, Ingkaninan K, Gleeson MP..  (2019)  Design, synthesis and evaluation of N2,N4-diaminoquinazoline based inhibitors of phosphodiesterase type 5.,  29  (2): [PMID:30509781] [10.1016/j.bmcl.2018.11.043]

Source